Lucier participates in Fort Worth innovation summit
Dr. Guangrong Lu represented Lucier at an academic and industry collaboration forum hosted by the Fort Worth–Tarrant County Innovation Partnership and Texas A&M–Fort Worth.
Company announcement from Lucier Pharmaceuticals.
Lucier Pharmaceuticals participated in the third annual Innovation Summit: Putting Ideas Into Action, hosted by the Fort Worth–Tarrant County Innovation Partnership and Texas A&M–Fort Worth.
Founder and CEO Dr. Guangrong Lu attended the summit on March 2, 2026, as Lucier explored opportunities for academic and industry collaboration and a future presence in the Dallas–Fort Worth area.
Lucier's programs build on scientific findings in coronary microcirculation originating at the Texas A&M Naresh K. Vashisht College of Medicine. The company values opportunities to strengthen the regional partnerships that can translate scientific discovery into potential new therapies.
Lucier's product candidates are investigational and in preclinical development. They have not been approved for patient use.